| Whitepapers – 10/31/20* |
Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) |
DHHS |
| Open |
COVID-19 Open Research Dataset Challenge (CORD-19) |
Kaggle |
| 10/5/2020 |
NOSI: Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) |
NIH |
| Continuous Submission |
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) |
NIH/DHHS |
| 2/16/2021* |
Clinical Trial Planning: Therapeutic/Indication Pairing Strategies (U34) (Clinical Trial Not Allowed) |
National Center for Advancing Translational Sciences/NIH/DHHS |
| Rolling through: 5/1/2021 |
(NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) |
NIA/NIMH |
| 9/30/2020 |
CSO COVID 19 Response |
Department of Defense |
| 11/18/2020 |
Ecology and Evolution of Infectious Diseases (EEID) |
NSF |
| None* |
Fast Funding for COVID-19 Science |
Fast Grants |
| Rolling submission: 3/25/2020 to 7/2/2021 |
NOSI regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) |
NIAID |
| Rolling submission: 3/25/2020 to 2/5/2021 |
NOSI regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 |
NIGMS |
| 10/16/2020* |
NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
|
NIH/DHHS |
| 10/5/2020 |
NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
|
NIH/DHHS |
| 2/3/2023 |
BARDA’s Division of Research, Innovation & Ventures (DRIVe) Easy Broad Agency Announcement |
DHHS |
| 10/16/2020* |
NIBIB Exploratory/Developmental Research Grant Program (R21 Clinical Trial Optional) |
NIBIB/NIH/DHHS |
| Rolling through: 5/3/2021* |
(NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) |
NIEHS/NIH/DHHS |
| 10/16/2020* |
NIBIB Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional) |
NIBIB/NIH/DHHS |
| 10/5/2020 |
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional) |
NIH/DHHS |
| 10/5/2020 |
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 – Clinical Trial Optional) |
National Cancer Institute/NIH/DHHS |
| 10/16/2020* |
NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed) |
NIH/DHSS |
| Rolling through: 4/15/2021 |
Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement – Clinical Trial Optional) |
NIH/DHHS |
| Rolling through: 4/15/2021 |
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
|
NIH/DHHS |
| 10/16/2020* |
NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed) |
NIH/DHHS |
| 10/5/2020 |
Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional) |
NIH/DHHS |
| 2/3/2023 |
BARDA’s Division of Research, Innovation & Ventures (DRIVe) Easy Broad Agency Announcement |
DHHS |
| 2/5/2021 |
Clinic Testing Therapeutic/Indication Pairing Strategies (U01 Clinical Trial Required) |
NCATS/NIH/DHHS |
| 12/12/2020* |
Research Innovation Collaborations Program |
23andme |
| Rolling: 5/1/2020- 10/5/2020 |
Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement – Clinical Trial Optional) |
NIH/DHHS |
| 10/16/2020* |
NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed) |
NIH/DHHS |
| 11/13/2020 |
Implementing the HIV Service Cascade for Justice-Involved Populations (U01 Clinical Trial Required) |
National Institute on Drug Abuse/NIH/DHHS |
| None Posted |
Expedited, Rapid Access Call for COVID-19 Research |
Argonne National Laboratory |
| None Posted |
COVID-19 Response: A Call for Ideas |
Mercatus Center |
| Rolling through: 10/6/2020 |
Notice of Special Interest (NOSI): Availability of Administrative Supplements and Urgent Competitive Revisions for Research on Stress Management in Relation to Coronavirus Disease 2019 (COVID-19) |
NCCIH, NIA, NIAAA |
| Rolling through: 5/1/2021 |
Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities |
NIMHD |
| Rolling through: 1/25/2022 |
Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel Coronavirus |
NCATS |
| Rolling through: 4/16/2021 |
Notice of Special Interest: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA |
NIAAA |
| Rolling through: 3/31/2021 |
Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences |
NIH |
| Rolling starting: 4/29/2020 |
Rapid Acceleration of Diagnostics (RADx): Fast-Track Program for COVID-19 Test Development and Distribution |
NIBIB/NIH/DHHS |
| 9/1/2022 |
National Dental Practice-Based Research Network Infrastructure Access (X01 Clinical Trial Not Allowed) |
NIDCR/NIH/DHHS |
| None posted |
Grants Program |
COVID-19 Early Treatment Fund (CETF) |
| None posted |
COVID-19 Rapid Response Fund |
Jacob and Valeria Langeloth Foundation |
| 11/1/2020 |
Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements for Coronavirus Disease 2019 (COVID-19) Research within the Mission of NIDCR |
NIDCR |
| 11/2/2022 |
Notice of Special Interest (NOSI): Infrastructure Access for Research on Coronavirus Disease 2019 (COVID-19) Conducted in the National Dental Practice-Based Research Network |
NIDCR |
| 9/30/2020 |
NIH Director’s Emergency Transformative Research Awards (R01 Clinical Trial Optional) |
NIH/DHHS |
| 10/5/2020 |
NOSI: Promoting Fundamental and Applied Research in Inflammation Resolution |
NIEHS/NHLBI/NIAMS |
| 10/17/2020 |
Alcohol-HIV/AIDS Program Project Comorbidities, Coinfections, and Complications Research: Intervention and Cross-Cutting Foundational Research (P01 Clinical Trial Optional) |
NIAAA/NIH/DHHS |
| Rolling |
Decentralized Clinical Studies RFP |
Gateway for Cancer Research |
| 12/15/2020 |
Notice of Special Interest (NOSI): Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 |
NIH/DHHS |
| 12/15/2020 |
Notice of Special Interest (NOSI): Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations |
NIH/DHHS |
| None |
Guide Notice of Information Highlighting Harmonization and Data Sharing Expectations for Supplement and Revision Projects Addressing Social, Behavioral, Economic and Health Impacts of the COVID-19 Public Health Emergency |
National Institute on Deafness & Other Communication Disorders/NIH/DHHS |
| Rolling |
RWJF Evidence for Action: Investigator-Initiated Research to Build a Culture of Health |
Robert Wood Johnson Foundation |
| Rolling |
Alkermes Education Grants |
Alkermes |
| Rolling |
Golden LEAF Open Grants Program |
Golden LEAF |
| 10/6/2020 |
|
NIH/NIDA/NCI |
| 10/1/2020* |
NIA Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics In At-risk Older Adult Populations (R01 Clinical Trial Required) |
NIA/NIH/DHHS |
| 11/10/2020 |
Notice of Special Interest (NOSI): New Administrative Supplement Applications to UL1 and U24 CTSA Awards to Address COVID-19 Public Health Need |
NIH/DHHS |
| Rolling from 7/10/2020 – 12/15/2020 |
Notice of Special Interest (NOSI): Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations |
NIH/DHHS |
| 10/13/2020 |
Laboratory, Data Analysis, and Coordinating Center (LDACC) for the Developmental Genotype-Tissue Expression Project (U24 Clinical Trial Not Allowed) |
NIH/DHHS |
| 11/12/2020* |
Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Project |
NIH/DHHS |
| 9/30/2020 |
FDA COVID-19 Diagnostic Test Fellowship |
Oak Ridge Institute for Science and Education FDA-CBER-2020-0052 |
| 9/30/2020 |
FDA Influenza Immunity and Vaccination Postdoctoral Fellowship |
Oak Ridge Institute for Science and Education FDA-CBER-2020-0051 |
| None Posted |
Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement – Clinical Trial Optional) |
NIH/DHHS |
| None Posted |
Covid-19 Research Credits Program |
Google |
| 10/2/2020 |
Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 – Clinical Trial Optional) |
NIH/DHHS |
| 2/3/2023 |
Division of Research, Innovation & Ventures (DRIVe) Easy Broad Agency Announcement |
BARDA/DHHS |
| 3/10/2021 |
Flash Grants |
North Carolina Biotechnology Center |
| Rolling starting 8/31/2020 |
Just Tech Covid-19 Rapid-Response Grants |
Social Science Research Council |
9/16/2020
[Optional] [LOI/Pre-App] |
Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional) |
NIDDKD/NIH/DHHS |
| 9/16/2020 |
Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional) |
NIDDKD/NIH/DHHS |
Rolling starting:
7/13/2020 |
Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed) |
NIAID/NIH/DHHS |
| 9/18/2020 |
Ecology and Evolution of Infectious Diseases (EEID) |
NSF |
| 11/18/2020 |
Ecology and Evolution of Infectious Diseases (EEID) |
NSF |
| Rolling |
Small Grants Program in Behavioral Economics |
Sage (Russell) Foundation |
| 9/15/2020 |
Competitive Grant Program: Improving Disparities in Rheumatoid Arthritis Health Care in Post COVID-19 Era in memory of Cinzia Curiale |
Pfizer Pharmaceuticals |
| none |
Dear Colleague Letter: Sentinel Cells for Surveillance and Response to Emergent Infectious Diseases (Sentinels) |
NSF |
| Rolling start: 8/6/2020 |
Urgent Phase I/II Clinical Trials to Repurpose Existing Therapeutic Agents to Treat COVID-19 Sequelae (U01 Clinical Trial Required) |
NIH/DHHS |
| 5/28/2021 |
COVID-19 Private Sector Engagement & Partnership Fund |
DOS |
8/21/2020
[Optional] [LOI/Pre-App]
9/15/2020 |
Emergency Awards: Automatic Detection and Tracing of SARS-CoV-2 (U01 Clinical Trial Not Allowed) |
NIH/DHHS |
8/31/2020
[Optional] [LOI/Pre-App] |
Emergency Awards: RADx-rad Data Coordination Center (DCC) (U24 Clinical Trial Not Allowed) |
NIH/DHHS |
| 9/15/2020 |
Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Chemosensory Testing as a COVID-19 Screening Tool |
NIH/DHHS |
8/18/2020
[Optional] [LOI/Pre-App]
9/18/2020 |
Emergency Awards: Exosome-based Non-traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS-CoV-2 (U18 Clinical Trial Not Allowed) |
NIH/DHHS |
| 9/15/2020 |
Emergency Awards: Chemosensory Testing as a COVID-19 Screening Tool (U01 Clinical Trial Optional) |
NIH/DHHS |
8/15/2020
[Optional] [LOI/Pre-App]
9/15/2020 |
Emergency Awards: RADx-rad Wastewater Detection of SARS-COV-2 (COVID-19) (U01 – Clinical Trials Not Allowed) |
NIH/DHHS |
8/18/2020
[Optional] [LOI/Pre-App]
9/18/2020 |
Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (Fast-Track STTR Clinical Trial Not Allowed) |
NIH/DHHS |
8/18/2020
[Optional] [LOI/Pre-App]
9/18/2020 |
Emergency Awards RADx-RAD: Screening for COVID-19 by Electronic-Nose Technology (SCENT) (U18 Clinical Trial Not Allowed) |
NIH/DHHS |
8/18/2020
[Optional] [LOI/Pre-App]
9/18/2020 |
Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (R44 Clinical Trial Not Allowed) |
NIH/DHHS |
| 10/5/2020 |
Emergency Awards: RADx-RAD Multimodal COVID-19 Surveillance Methods for High Risk Clustered Populations (R01 Clinical Trial Optional) |
NIH/DHHS |
8/31/2020
[Optional] [LOI/Pre-App]
9/30/2020 |
Emergency Awards: RADx-rad Predicting Viral-Associated Inflammatory Disease Severity in Children with Laboratory Diagnostics and Artificial Intelligence (PreVAIL kIds) (R61/R33 Clinical Trial Optional) |
NIH/DHHS |
| 10/5/2020 |
Notice of Special Interest (NOSI): Comprehensive Care for Adults with Type 2 Diabetes Mellitus from Health Disparity Populations |
NIMH/NIH/DHHS |
| 10/14/2020 |
Notice of Special Interest (NOSI): Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates Against SARS-CoV-2 |
NIAID/NIH/DHHS |
| 10/5/2020 |
Notice of Special Interest (NOSI): Simulation Modeling and Systems Science to Address Health Disparities |
NIH/DHHS |
| 10/30/2020 |
2020 TIP Office Annual Program Statement to Address the Impacts of COVID-19 |
DOS |
| 9/18/2020 |
Epilepsy Research Continuity Find (ERCF) |
Citizens United for Research in Epilepsy |
| 9/18/2020 |
Futures Forum on Learning: Tools Competition |
Schmidt Futures |
| 10/6/2020 |
Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional) |
NIDA/NIH/DHHS |
| 10/14/2020 |
Implementing the HIV Service Cascade for Justice-Involved Populations (U01 Clinical Trial Required) |
NIDA/NIH/DHHS |
| 9/7/2020 |
NIBIB Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional) |
NIBIB/NIH/DHHS |
| 10/5/2020 |
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional) |
NIH/DHHS |
| 9/7/2020 |
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 – Clinical Trial Optional) |
NCI/NIH/DHHS |
| 9/7/2020 |
NIBIB Exploratory/Developmental Research Grant Program (R21 Clinical Trial Optional) |
NIBIB/NIH/DHHS |
| None |
NIBIB Research Project Grant (R01 Clinical Trial Required) |
NIH/DHHS |
8/31/2020 [Optional] [LOI/Pre-App]
9/30/2020 |
Emergency Awards: RADx-rad Predicting Viral-Associated Inflammatory Disease Severity in Children with Laboratory Diagnostics and Artificial Intelligence (PreVAIL kIds) (R61/R33 Clinical Trial Optional) |
NIH/DHHS |
| 1/5/2021 |
NIBIB Exploratory Clinical Trials for Small Business (R44 Clinical Trial Required) |
NIBIB/NIH/DHHS |
| 9/21/2020 [LOI/Pre-App] |
Foundation for Women’s Cancer Diversity and Inclusion Health Equity Research Grant |
Foundation for Women’s Cancer |
| 11/13/2020 |
Research Aid Awards: COVID-19 Related Outcomes |
American Association of Orthodontists Foundation |
| 11/13/2020 |
Center Awards: COVID-19 Related Outcomes |
American Association of Orthodontists Foundation |
| 11/13/2020 |
Postdoctoral Fellowship Award: COVID-19 Related Outcomes |
American Association of Orthodontists Foundation |
| 11/13/2020 |
Orthodontic Faculty Development Fellowship Awards: COVID-19 Related Outcomes |
American Association of Orthodontists Foundation |
| 11/13/2020 |
Biomedical Research Awards: COVID-19 Related Outcomes |
American Association of Orthodontists Foundation |
| 9/15/2020 |
SVRI Research Grant |
Sexual Violence Research Initiative |
| 10/8/2020 |
ACM Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research |
Association for Computing Machinery |
| 10/5/2020 |
Emerging Viral Infections and their Impact on the Male and Female Reproductive Tract |
NICHD/NIH/DHHS |
| 10/1/2020 |
Mechanism for Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed) |
NIEHS |
| 9/29/2020 |
Johnson & Johnson Nurses Innovate QuickFire Challenge in COVID-19 Patient Care |
Johnson & Johnson |
| 10/1/2020 |
Emerging Needs: COVID-19 Response and Future Mitigation |
Dept. of Homeland Security |
| 9/29/2020 |
COVID-19 Symptom Data Challenge |
Catalyst @ Health 2.0 |
| 10/30/2020 |
Seeking Community Input for Topic Ideas for Emerging Frontiers in Research and Innovation (EFRI) Program |
NSF |
| 12/12/2020 |
Research Innovation Collaborations Program |
23andme |
| 10/15/2020 |
Medical Education Grants: The Burden and Origins of Co-Infections in COVID-19 Pneumonia |
Pfizer Pharmaceuticals |
| 10/5/2020 |
(NOSI): The Influence of Host Resilience on Heterogeneity of Acute Respiratory Distress Syndrome/Acute Lung Injury (ARDS/ALI) |
NIH/DHHS |
| 10/25/2020 |
The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional) |
ORWH/NIH/DHHS |
